Listar por tema 

Listar por tema "lymphoma"

Mostrando ítems 1-5 de 5

    • Anxiety prevalence in lymphoma: A systematic review and meta-analysis 

      Vargas-Román, Keyla; Díaz-Rodríguez, C. Lourdes; Cañadas-de la Fuente, Guillermo Arturo; Gómez Urquiza, José Luis; Ariza, Tania ; Fuente -Solana, Emilia I. de la (Health Psychology, 07/2020)
      Objective: Hodgkin and non-Hodgkin lymphoma patients are at high risk of experiencing anxiety because the clinical processes and therapies they undergo produce strong adverse effects. In this review we discuss the prevalence ...

    • Castleman's disease: one disease, multiple etiologies 

      Esteban-Sampedro, Jorge; Martín-Portugués, Mario; Durán-del Campo, Pedro; Fernández-Güitián, Román; Ruiz-Becerra, Jaime E.; Moreno-Torres, Víctor (AIDS Review, 2024)
      Castleman disease (CD) comprises a heterogeneous group of rare lymphoproliferative disorders characterized by similar morphological features in nodal biopsies. Since Benjamin Castleman's initial description in 1956, our ...

    • Higher mortality risk from lung and hematological neoplasms in patients with rheumatoid arthritis: An observational study from the Spanish National Registry 

      Esteban-Sampedro, Jorge; Moreno-Torres, Víctor; Martín-Portugués, Mario (Medicina Clínica, 2024)
      Objective: Evaluating the impact of solid organ neoplasms (SON) and hematological neoplasms (HN) on mortality among RA patients in a nationwide study. Methods: A retrospective, observational comparison of SON and ...

    • Neoplasm related mortality risk in Systemic Sclerosis: a nationwide study 

      Martínez-Urbistondo, María; González-Guzmán, Antonio; Fernández-Guitián, Román; Blanco-Valencia, Xiomara Patricia; Esteban-Sampedro, Jorge; Martín-Portugués, Mario; Durán-del Campo, Pedro; Tutor, Pablo; Mellor-Pita, Susana; Ortega-de la Puente, Alfonso; de la Cruz-Echeandía, Marina; Moreno-Torres, Víctor (BMC Rheumatology, 2025)
      Background The higher mortality rates in patients with Systemic sclerosis (SSc) are related to SSc activity, cardiovascular disease, and neoplasms, among other factors. Our objective was to assess the impact of solid ...

    • Sarcoidosis and lymphoma mortality risk: An observational study from the Spanish National Registry 

      Moreno-Torres, Víctor; Martínez-Urbistondo, María; Durán-del Campo, Pedro; Tutor, Pablo; Rodríguez, Begoña; Castejón, Raquel; Mellor-Pita, Susana (Journal of Translational Autoimmunity, 2024)
      Introduction: Patients with sarcoidosis have a lower survival rate than the general population, in part due to cardiovascular disease, infections and neoplasms. Our objective was to evaluate the impact of haematological ...